Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Incyte Corporation
Incyte Corporation
University of Florida
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
University of Illinois at Chicago
Medical College of Wisconsin
Shenzhen TargetRx, Inc.
Jiangsu Hansoh Pharmaceutical Co., Ltd.